|
AU736912B2
(en)
*
|
1997-02-20 |
2001-08-02 |
Therics, Inc. |
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
|
|
DK2263660T3
(en)
*
|
1998-05-18 |
2018-01-02 |
Takeda Pharmaceuticals Co |
Orally disintegrating tablets.
|
|
US6284270B1
(en)
*
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
|
AU2001273687A1
(en)
*
|
2000-07-10 |
2002-01-21 |
Massachusetts Institute Of Technology |
Method and materials for controlling migration of binder liquid in a powder
|
|
DE60232445D1
(de)
*
|
2001-06-28 |
2009-07-09 |
Ucb Farchim Sa |
Cetirizin und pseudoephedrin enthaltende tablette
|
|
IL159715A0
(en)
*
|
2001-07-10 |
2004-06-20 |
Teva Pharma |
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
|
|
JP2005509001A
(ja)
*
|
2001-10-29 |
2005-04-07 |
セリクス， インコーポレイテッド |
投薬形態の三次元懸濁液プリンティング
|
|
US7931914B2
(en)
*
|
2001-10-29 |
2011-04-26 |
Massachusetts Institute Of Technology |
System and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form
|
|
DE60323482D1
(de)
*
|
2002-05-06 |
2008-10-23 |
Massachusetts Inst Technology |
Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
|
|
MXPA05005528A
(es)
|
2002-11-26 |
2006-04-05 |
Alk Abello As |
Producto farmaceutico de alergeno.
|
|
EP1804804B1
(en)
|
2004-09-21 |
2012-01-25 |
Hypnion, Inc. |
3-[4-(DIBENZO[b,f][1,4]OXAZEPIN-11-YL)-PIPERAZIN-1-YL]-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS
|
|
US7829000B2
(en)
*
|
2005-02-25 |
2010-11-09 |
Hewlett-Packard Development Company, L.P. |
Core-shell solid freeform fabrication
|
|
US8187659B2
(en)
|
2006-05-02 |
2012-05-29 |
Jerry Robertson Real Estate Llc |
Solid medicament dosage form consumption aid
|
|
WO2008002676A2
(en)
|
2006-06-29 |
2008-01-03 |
Kinex Pharmaceuticals, Llc |
Biaryl compositions and methods for modulating a kinase cascade
|
|
EP3777832A1
(en)
|
2007-10-20 |
2021-02-17 |
Athenex, Inc. |
Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
|
|
US12186426B2
(en)
|
2009-10-30 |
2025-01-07 |
Ix Biopharma Ltd. |
Solid dosage form
|
|
DK3254676T3
(en)
|
2009-10-30 |
2019-03-11 |
Ix Biopharma Ltd |
QUICK-SOLVING SOLID DOSAGE FORM
|
|
JP2013524275A
(ja)
*
|
2010-04-03 |
2013-06-17 |
ドシ，プラフル |
薬剤を含む医療機器、その製造方法とその使用方法
|
|
EP2632920A1
(en)
|
2010-10-27 |
2013-09-04 |
Dynamix Pharmaceuticals Ltd. |
Sulfonamides for the modulation of pkm2
|
|
WO2012088438A1
(en)
|
2010-12-22 |
2012-06-28 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
|
WO2012106058A2
(en)
|
2011-01-31 |
2012-08-09 |
New Market Pharmaceuticals |
Animal treatments
|
|
US9051305B2
(en)
|
2011-03-08 |
2015-06-09 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
|
ITMI20110792A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
|
|
ITMI20110793A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
|
|
ITMI20110791A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri in grado di metabolizzare gli ossalati.
|
|
WO2012160447A1
(en)
|
2011-05-25 |
2012-11-29 |
Dynamix Pharmaceuticals Ltd. |
3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
|
|
ES2585244T3
(es)
|
2011-06-07 |
2016-10-04 |
Clevexel Pharma |
Composiciones y métodos para modular una cinasa
|
|
ITMI20111718A1
(it)
|
2011-09-23 |
2013-03-24 |
Probiotical Spa |
Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
|
|
US9245061B2
(en)
*
|
2012-04-25 |
2016-01-26 |
Shapeways, Inc. |
Weight-based identification of three dimensional printed parts
|
|
WO2013165468A1
(en)
|
2012-05-02 |
2013-11-07 |
New Market Pharmaceuticals |
Pharmaceutical compositions for direct systemic introduction
|
|
US20150150869A1
(en)
|
2012-06-20 |
2015-06-04 |
Eutropics Pharmaceuticals, Inc. |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
|
|
US9926273B2
(en)
|
2012-08-30 |
2018-03-27 |
Athenex, Inc. |
Composition and methods for modulating a kinase cascade
|
|
WO2014116770A1
(en)
|
2013-01-23 |
2014-07-31 |
Arx, Llc |
Production of unit dose constructs
|
|
ES2761265T3
(es)
*
|
2013-03-15 |
2020-05-19 |
Aprecia Pharmaceuticals LLC |
Forma de dosificación de oxcarbazepina rápidamente dispersable
|
|
JP6466399B2
(ja)
|
2013-03-15 |
2019-02-06 |
アプレシア・ファーマスーティカルズ・カンパニー |
トピラマートの急速分散性の剤形
|
|
US9339489B2
(en)
|
2013-03-15 |
2016-05-17 |
Aprecia Pharmaceuticals Company |
Rapid disperse dosage form containing levetiracetam
|
|
MX365513B
(es)
|
2013-03-15 |
2019-06-06 |
Aprecia Pharmaceuticals LLC |
Forma de dosificacion de dispersion rapida que contiene levetiracetam.
|
|
US10994013B2
(en)
|
2013-04-24 |
2021-05-04 |
Temple University—Of the Commonwealth System of Higher Education |
Solid dosage form containing arabinogalactan
|
|
ITMI20130793A1
(it)
|
2013-05-14 |
2014-11-15 |
Probiotical Spa |
Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
|
|
KR102171123B1
(ko)
|
2013-08-16 |
2020-10-29 |
더 엑스원 컴퍼니 |
３차원 인쇄된 금속 주조용 몰드 및 그를 제조하기 위한 방법
|
|
WO2015057761A1
(en)
|
2013-10-17 |
2015-04-23 |
The Exone Company |
Three-dimensional printed hot isostatic pressing containers and processes for making same
|
|
WO2015100086A1
(en)
|
2013-12-23 |
2015-07-02 |
The Exone Company |
Methods and systems for three-dimensional printing utilizing multiple binder fluids
|
|
US11001048B2
(en)
|
2013-12-23 |
2021-05-11 |
The Exone Company |
Method of three-dimensional printing using a multi-component build powder
|
|
WO2015100085A2
(en)
*
|
2013-12-23 |
2015-07-02 |
The Exone Company |
Methods and systems for three-dimensional printing utilizing a jetted-particle binder fluid
|
|
EP3137113A4
(en)
*
|
2014-04-30 |
2017-03-22 |
Blaesi, Aron H. |
Melt-processed polymeric cellular dosage form
|
|
US20170120329A1
(en)
|
2014-05-29 |
2017-05-04 |
The Exone Company |
Process for Making Nickel-Based Superalloy Articles by Three-Dimensional Printing
|
|
US20170203514A1
(en)
|
2014-07-17 |
2017-07-20 |
The Exone Company |
Methods and Apparatuses for Curing Three-Dimensional Printed Articles
|
|
EA038518B1
(ru)
|
2014-11-21 |
2021-09-09 |
Биохэйвен Фармасьютикал Холдинг Компани Лтд. |
Сублингвальный препарат рилузола
|
|
US20180001551A1
(en)
|
2014-12-03 |
2018-01-04 |
The Exone Company |
Process for Making Densified Carbon Articles by Three Dimensional Printing
|
|
CA3254279A1
(en)
|
2015-06-03 |
2025-03-18 |
Triastek, Inc. |
PHARMACEUTICAL FORMS AND RELATED USES
|
|
EP3108874A1
(en)
*
|
2015-06-26 |
2016-12-28 |
TRB Chemedica AG |
Ophthalmologic pharmaceutical composition
|
|
US11129798B2
(en)
|
2016-08-19 |
2021-09-28 |
Aron H. Blaesi |
Fibrous dosage form
|
|
WO2017075096A1
(en)
*
|
2015-10-26 |
2017-05-04 |
Blaesi Aron H |
Solid dosage form immediate drug release and apparatus and method for manufacture thereof
|
|
JP2019508449A
(ja)
*
|
2016-03-18 |
2019-03-28 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
種々の効能を有する薬物の組み合わせ
|
|
ITUA20162013A1
(it)
|
2016-03-24 |
2017-09-24 |
Probiotical Spa |
Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
|
|
US20190217531A1
(en)
*
|
2016-04-06 |
2019-07-18 |
Astellas Pharma Inc. |
Fast-eluting three-dimensionally molded object, filament for fast-eluting three-dimensionally molded object, and material for fast-eluting three-dimensionally molded object
|
|
CA3023278C
(en)
|
2016-05-05 |
2019-04-30 |
Triastek, Inc. |
Controlled release dosage form
|
|
WO2017201502A1
(en)
|
2016-05-20 |
2017-11-23 |
Biohaven Pharmaceutical Holding Company Ltd. |
Use of glutamate modulating agents with immunotherapies to treat cancer
|
|
CN118384166A
(zh)
|
2016-08-12 |
2024-07-26 |
阿西纳斯公司 |
用于调节激酶级联的联芳组合物和方法
|
|
EP3529023B1
(en)
|
2016-10-19 |
2022-05-25 |
Shapeways, Inc. |
Systems and methods for identifying three-dimensional printed objects
|
|
KR102793584B1
(ko)
|
2016-12-31 |
2025-04-09 |
바이오엑셀 테라퓨틱스 인코포레이티드 |
불안의 치료를 위한 설하 덱스메데토미딘의 용도
|
|
KR20190107712A
(ko)
|
2017-01-26 |
2019-09-20 |
트리아스텍 인코포레이티드 |
특정 위장 부위에서의 제어 방출의 투여 형태
|
|
WO2018156141A1
(en)
*
|
2017-02-24 |
2018-08-30 |
Hewlett-Packard Development Company, L.P. |
Three-dimensional (3d) printing a pharmaceutical tablet
|
|
EA201992116A1
(ru)
|
2017-03-08 |
2020-01-29 |
СИНРКС ФАРМА, ЭлЭлСи |
Фармацевтические составы флороглюцинола и триметилфлороглюцинола
|
|
KR102626745B1
(ko)
|
2017-05-26 |
2024-01-17 |
인피니트 머티리얼 솔루션즈, 엘엘씨 |
수용성 중합체 조성물
|
|
EP3706739B1
(en)
|
2017-11-12 |
2024-10-16 |
Biohaven Therapeutics Ltd. |
Use of riluzole prodrugs to treat ataxias
|
|
CN108066302B
(zh)
*
|
2017-12-28 |
2020-09-11 |
无限极（中国）有限公司 |
一种快速分散固体制剂的制备方法及制备的快速分散固体制剂
|
|
US10350822B1
(en)
|
2018-01-09 |
2019-07-16 |
Triastek Inc. |
Dosage forms with desired release profiles and methods of designing and making thereof
|
|
CN116270513A
(zh)
|
2018-01-09 |
2023-06-23 |
南京三迭纪医药科技有限公司 |
一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
|
|
DE102018107585B3
(de)
*
|
2018-03-29 |
2019-03-28 |
Universität Rostock |
Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
|
|
PL3813802T3
(pl)
|
2018-06-27 |
2025-04-22 |
Bioxcel Therapeutics, Inc. |
Formulacje błony zawierające deksmedetomidynę i sposoby ich wytwarzania
|
|
WO2020081561A1
(en)
|
2018-10-15 |
2020-04-23 |
Aprecia Pharmaceuticals LLC |
Method and system for forming a dosage form within a packaging
|
|
EP3883546A1
(en)
|
2018-11-21 |
2021-09-29 |
Rosemont Pharmaceuticals Ltd |
Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
|
|
US12103229B2
(en)
*
|
2019-03-15 |
2024-10-01 |
Ricoh Company, Ltd. |
Jettable temporary binders to create removable support materials
|
|
JP7287032B2
(ja)
|
2019-03-20 |
2023-06-06 |
株式会社リコー |
シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法
|
|
BR112021023189A2
(pt)
*
|
2019-05-21 |
2022-01-04 |
Dfe Pharma Gmbh & Co Kg |
Uso de partículas de lactose na produção de formulações farmacêuticas por impressão tridimensional, kit, e, processo para preparar uma formulação farmacêutica sólida por impressão tridimensional
|
|
EP3999058A4
(en)
|
2019-07-19 |
2023-05-03 |
Bioxcel Therapeutics, Inc. |
NON-SEDATIVE DEXMEDETOMIDINE-BASED TREATMENT REGIMEN
|
|
EP3789015A1
(en)
*
|
2019-09-05 |
2021-03-10 |
Universität Innsbruck |
Fast consolidating compounds
|
|
TWI734309B
(zh)
*
|
2019-12-19 |
2021-07-21 |
水星生醫股份有限公司 |
滲透性噴塗製作藥錠裝置
|
|
US12371581B2
(en)
|
2020-03-25 |
2025-07-29 |
Infinite Material Solutions, Llc |
High performance water soluble polymer compositions
|
|
AU2021296908A1
(en)
|
2020-06-26 |
2023-02-16 |
Aprecia Pharmaceuticals LLC |
Rapidly-orodispersible tablets having an interior cavity
|
|
WO2022089588A1
(zh)
|
2020-10-30 |
2022-05-05 |
南京三迭纪医药科技有限公司 |
胃滞留药物剂型
|
|
EP4277624B1
(en)
|
2021-01-18 |
2026-01-14 |
Biohaven Therapeutics Ltd. |
Troriluzole for use in the treatment of alzheimer's disease of mild severity
|
|
WO2024108082A1
(en)
|
2022-11-18 |
2024-05-23 |
Aprecia Pharmaceuticals LLC |
Orodispersive dosage forms containing droxidopa
|
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|